HB 666

  • Maryland House Bill
  • 2017 Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee

Abstract

Bill Sponsors (74)

B. Barnes

     
Cosponsor

D. Barnes

     
Cosponsor

Davis

     
Cosponsor

C. Howard

     
Cosponsor

Kelly

     
Cosponsor

A. Miller

     
Cosponsor

Oaks

     
Cosponsor

Patterson

     
Cosponsor

Proctor

     
Cosponsor

Robinson

     
Cosponsor

Sophocleus

     
Cosponsor

Turner

     
Cosponsor

A. Washington

     
Cosponsor

M. Washington

     
Cosponsor

C. Wilson

     
Cosponsor

K. Young

     
Cosponsor

P. Young

     
Cosponsor

R. Lewis

     
Cosponsor

Votes


No votes to display

Actions


Feb 08, 2017

Maryland General Assembly

Hearing 2/23 at 1:00 p.m.

Feb 01, 2017

Maryland General Assembly

First Reading Health and Government Operations

Bill Text

Bill Text Versions Format
Bill Text PDF

Related Documents

Document Format
Fiscal and Policy Note PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Maryland General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.